Diet, Gut Microbiome, and Microbial Metabolites in Inflammatory Bowel Disease: From Functional Dysbiosis to Precision Nutrition
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27125262 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Josko Bozic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia. Hauptthemen laut MEDLINE: Dysbiosis, Inflammatory Bowel Diseases, Gastrointestinal Microbiome, Diet. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inflammatory bowel disease (IBD; Crohn’s disease and ulcerative colitis) arises from convergent dysfunction of the epithelial barrier, mucosal immunity, and gut microbiome on a background of genetic susceptibility and environmental exposures. Diet is among the most modifiable of these exposures, yet much of the diet–microbiome research in IBD remains descriptive and poorly aligned with the molecular pathways linking food to mucosal effects. This comprehensive review reframes the field around functional dysbiosis, in which altered microbial metabolic capacity (rather than taxonomic shifts alone) drives disease-relevant biology. We trace how dietary substrates and additives are converted by gut microbes into bioactive metabolites (short-chain fatty acids, secondary bile acids, tryptophan-derived indoles, sulfur compounds, and polyphenol-derived molecules) and map these to host receptors and signaling pathways governing barrier function, mucus and antimicrobial peptide production, and Treg/Th17 balance. Defined dietary therapies (exclusive enteral nutrition, the Crohn’s disease exclusion diet plus partial enteral nutrition, and Mediterranean-style patterns) are reinterpreted as interventions that reshape microbial metabolic output, and candidate biomarkers for microbiome-informed precision nutrition are evaluated. Microbiota-derived metabolites provide the molecular interface between diet and mucosal immunity in IBD; personalized dietary algorithms remain a research goal, not a validated clinical tool, and diet is best framed as adjunctive to pharmacotherapy and dietitian care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia.
- Laboratory for Cardiometabolic Research, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.
- Gastroenterology and Hepatology Department, University Hospital of Split, Spinciceva 1, 21000 Split, Croatia.
ORCID-Profile: Josko Bozic, Roko Santic, Marko Kumric
Zitieren
APA
Bozic, J., Santic, R., Zivkovic, P. M., & Kumric, M. (2026). Diet, Gut Microbiome, and Microbial Metabolites in Inflammatory Bowel Disease: From Functional Dysbiosis to Precision Nutrition. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27125262
Vancouver
Bozic J, Santic R, Zivkovic PM, Kumric M. Diet, Gut Microbiome, and Microbial Metabolites in Inflammatory Bowel Disease: From Functional Dysbiosis to Precision Nutrition. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27125262
BibTeX
@article{Bozic2026,
author = {Bozic, Josko and Santic, Roko and Zivkovic, Piero Marin and Kumric, Marko},
title = {Diet, Gut Microbiome, and Microbial Metabolites in Inflammatory Bowel Disease: From Functional Dysbiosis to Precision Nutrition},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27125262}
}
EUVIMED